Similar articles

• Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation.

  Bruce DS, Woodle ES, Newell KA, Millis JM, Cronin DC 2nd, Loss GE, Pellar S, Josephson MA, Thistlethwaite JR Jr. Bruce DS, et al. Transplant Proc. 1998 Mar;30(2):507-8. doi: 10.1016/s0041-1345(97)01378-x. Transplant Proc. 1998. PMID: 9532150 No abstract available.
• [Mycophenolate mofetil in renal transplantation].

  Uchida K. Uchida K. Nihon Rinsho. 2005 May;63 Suppl 5:684-91. Nihon Rinsho. 2005. PMID: 15954430 Review. Japanese. No abstract available.
• Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patients.

  van Gelder T, Smak Gregoor PJ, Weimar W. van Gelder T, et al. Ther Drug Monit. 2000 Oct;22(5):639. doi: 10.1097/00007691-200010000-00024. Ther Drug Monit. 2000. PMID: 11034275 No abstract available.
• Mycophenolate mofetil/tacrolimus/single-shot versus azathioprine/cyclosporine/ATG in pancreas-kidney transplantation: results of a prospective randomized single-center study.

  Büsing M, Martin D, Schulz T, Heimes M, Klempnauer J, Kozuschek W. Büsing M, et al. Transplant Proc. 1998 Mar;30(2):516-7. doi: 10.1016/s0041-1345(97)01383-3. Transplant Proc. 1998. PMID: 9532155 Clinical Trial. No abstract available.
• Individualization of mycophenolate mofetil dose in renal transplant recipients.

  van Hest RM, Hesselink DA, Vulto AG, Mathot RA, van Gelder T. van Hest RM, et al. Expert Opin Pharmacother. 2006 Mar;7(4):361-76. doi: 10.1517/14656566.7.4.361. Expert Opin Pharmacother. 2006. PMID: 16503809 Review.